Literature DB >> 22560521

Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective.

Bernadette A Mansi1, Juli Clark, Frank S David, Thomas M Gesell, Susan Glasser, John Gonzalez, Daniel G Haller, Christine Laine, Charles L Miller, LaVerne A Mooney, Maja Zecevic.   

Abstract

Mesh：

Year:  2012        PMID： 22560521      PMCID： PMC3538468          DOI： 10.1016/j.mayocp.2012.02.009

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  17 in total

1.  Enhancing transparency and efficiency in reporting industry-sponsored clinical research: report from the Medical Publishing Insights and Practices initiative.

Authors:  J Clark; J Gonzalez; B Mansi; C Miller; L A Mooney; K Mosdell; D Richards; M Schreiweis; A Weigel; E Wager
Journal:  Int J Clin Pract       Date:  2010-05-07       Impact factor: 2.503

2.  The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Authors:  O Bruyere; J A Kanis; M-E Ibar-Abadie; N Alsayed; M L Brandi; N Burlet; D L Cahall; A Chines; J-P Devogelaer; W Dere; N Goel; N Hughes; J-M Kaufman; S Korte; B H Mitlak; D Niese; R Rizzoli; L C Rovati; J-Y Reginster
Journal:  Osteoporos Int       Date:  2010-03-18       Impact factor: 4.507

3.  Authors' Submission Toolkit: a practical guide to getting your research published.

Authors:  Leighton Chipperfield; Leslie Citrome; Juli Clark; Frank S David; Robert Enck; Michelle Evangelista; John Gonzalez; Trish Groves; Jay Magrann; Bernadette Mansi; Charles Miller; LaVerne A Mooney; Ann Murphy; John Shelton; Philip D Walson; Al Weigel
Journal:  Curr Med Res Opin       Date:  2010-08       Impact factor: 2.580

4.  Putting research into context--revisited.

Authors:  Stephanie Clark; Richard Horton
Journal:  Lancet       Date:  2010-07-03       Impact factor: 79.321

5.  Online disclosure of physician-industry relationships.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2009-01-22       Impact factor: 91.245

6.  Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity?

Authors:  William L Lanier
Journal:  Mayo Clin Proc       Date:  2009-09       Impact factor: 7.616

7.  The potential for bias in reporting of industry-sponsored clinical trials.

Authors:  Stephen Pyke; Steven A Julious; Simon Day; Michael O'Kelly; Susan Todd; James Matcham; Jorgen Seldrup
Journal:  Pharm Stat       Date:  2011 Jan-Feb       Impact factor: 1.894

8.  Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study.

Authors:  Andrew P Prayle; Matthew N Hurley; Alan R Smyth
Journal:  BMJ       Date:  2012-01-03

9.  Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis.

Authors:  Joseph S Ross; Tony Tse; Deborah A Zarin; Hui Xu; Lei Zhou; Harlan M Krumholz
Journal:  BMJ       Date:  2012-01-03

10.  Bias, spin, and misreporting: time for full access to trial protocols and results.

Authors:  An-Wen Chan
Journal:  PLoS Med       Date:  2008-11-25       Impact factor: 11.069
View more
  13 in total

1.  Reducing age of autism diagnosis: developmental social neuroscience meets public health challenge.

Authors:  Ami Klin; Cheryl Klaiman; Warren Jones
Journal:  Rev Neurol       Date:  2015-02-25       Impact factor: 0.870

2.  Commenting on ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research.

Authors:  Thomas P Stossel; Lance K Stell
Journal:  Mayo Clin Proc       Date:  2012-09       Impact factor: 7.616

3.  Credibility of industry-sponsored clinical research: hype or hope?

Authors:  Alain Braillon
Journal:  Mayo Clin Proc       Date:  2012-09       Impact factor: 7.616

4.  Increasing value and reducing waste: addressing inaccessible research.

Authors:  An-Wen Chan; Fujian Song; Andrew Vickers; Tom Jefferson; Kay Dickersin; Peter C Gøtzsche; Harlan M Krumholz; Davina Ghersi; H Bart van der Worp
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

Review 5.  Publication bias, with a focus on psychiatry: causes and solutions.

Authors:  Erick H Turner
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

6.  Use of adjectives in abstracts when reporting results of randomized, controlled trials from industry and academia.

Authors:  M Soledad Cepeda; Jesse A Berlin; Susan C Glasser; Wendy P Battisti; Martijn J Schuemie
Journal:  Drugs R D       Date:  2015-03

7.  Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications.

Authors:  Ana Marušić; Darko Hren; Bernadette Mansi; Neil Lineberry; Ananya Bhattacharya; Maureen Garrity; Juli Clark; Thomas Gesell; Susan Glasser; John Gonzalez; Carolyn Hustad; Mary-Margaret Lannon; LaVerne A Mooney; Teresa Peña
Journal:  BMC Med       Date:  2014-10-24       Impact factor: 8.775

8.  Publication practices and standards: recommendations from GSK Vaccines' author survey.

Authors:  Isabelle Camby; Véronique Delpire; Laurence Rouxhet; Thomas Morel; Christine Vanderlinden; Nancy Van Driessche; Tatjana Poplazarova
Journal:  Trials       Date:  2014-11-18       Impact factor: 2.279

9.  Restoring invisible and abandoned trials: a call for people to publish the findings.

Authors:  Peter Doshi; Kay Dickersin; David Healy; S Swaroop Vedula; Tom Jefferson
Journal:  BMJ       Date:  2013-06-13

10.  Haphazard reporting of deaths in clinical trials: a review of cases of ClinicalTrials.gov records and matched publications-a cross-sectional study.

Authors:  Amy Earley; Joseph Lau; Katrin Uhlig
Journal:  BMJ Open       Date:  2013-01-18       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.